글로벌 신경광자학 시장 – 2031년까지의 산업 동향 및 예측

신경광자학 시장 분석 및 규모

신경 광자학 시장의 응용 분야인 신경 진단은 광학 기술을 사용하여 신경학적 상태를 진단하고 모니터링하는 것을 포함합니다. 근적외선 분광법(NIRS) 및 기능적 근적외선 분광법(fNIRS)과 같은 기술은 혈액 산소화 및 혈역학의 변화를 감지하여 뇌 활동을 비침습적으로 측정할 수 있게 합니다. 이러한 방법은 뇌 기능에 대한 실시간 통찰력을 제공하여 뇌졸중, 외상성 뇌 손상 및 인지 장애와 같은 장애의 진단을 돕습니다.

글로벌 신경광자학 시장 규모는 2023년에 15억 6천만 달러로 평가되었으며, 2031년까지 35억 6천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 10.88%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

신경광자학은 신경과학과 광자학을 결합하여 빛 기반 기술을 사용하여 뇌를 연구하는 분야입니다. 여기에는 레이저 이미징 및 분광법과 같은 광학적 방법을 사용하여 신경 활동을 시각화하고 조작하는 것이 포함됩니다. 이 접근 방식은 고해상도, 비침습적 뇌 기능 관찰 및 제어를 가능하게 하여 신경 과정에 대한 이해를 높이고 신경 장애 치료법 개발을 돕습니다.

신경광자학 시장 동향

Drivers                                                                                          

• Escalating Investments in Research and Development

High investments fuel groundbreaking discoveries and technological advancements, fostering the creation of innovative neurophotonics tools and applications. With governments, academic institutions, and private enterprises allocating substantial funds to neuroscience R&D, there's a surge in collaborative efforts and interdisciplinary research initiatives. This concerted focus on R&D enhances our understanding of neural processes, spurring the development of more sophisticated neurophotonics solutions for diagnostics, therapeutics, and basic neuroscience research. These investments stimulate market growth and hold the promise of revolutionizing neurological healthcare with cutting-edge optical technologies.

• Increased Focus on Precision Medicine

Precision medicine emphasizes tailoring medical treatments to individual characteristics, including genetic makeup, lifestyle, and environmental factors. Neurophotonics plays a crucial role in precision medicine by providing non-invasive, high-resolution imaging techniques for detailed mapping of neural structures and functions. This precision allows healthcare providers to diagnose neurological disorders more accurately, predict treatment responses, and personalize therapeutic interventions for better patient outcomes. As the demand for personalized healthcare grows, the adoption of neurophotonics technologies is expected to increase, driving market expansion and innovation in the field.

Opportunities

• Growing Prevalence of Neurological Disorders

Conditions such as Alzheimer's disease, Parkinson's disease, and stroke is rising globally due to which there's a growing demand for advanced diagnostic and therapeutic solutions. Neurophotonics technologies offer non-invasive and high-resolution imaging methods, enabling early detection, precise diagnosis, and monitoring of these disorders. Additionally, the complexity of neurological conditions necessitates better understanding of brain function, which neurophotonics facilitates through its ability to visualize neural activity in real-time. This demand is further fueled by the healthcare industry's focus on providing more personalized and targeted treatments, driving investment and innovation in neurophotonics research and development.

• High Advancements in Technology

These advancements have led to the development of innovative products and solutions that improve the diagnosis and treatment of neurological disorders. Technological advancements in pain management, for instance, have contributed to the growth of the neurophotonics market. Additionally, advancements in imaging and sensing technologies have enhanced the accuracy and effectiveness of neurophotonics-based treatments. These advancements are expected to continue driving market growth in the future.

Restraints/Challenges

• High Initial Investment Required

The substantial cost associated with purchasing advanced equipment, such as imaging systems and laser devices, as well as the expenses related to training personnel and maintaining the infrastructure, can deter healthcare facilities and research institutions from adopting neurophotonics solutions. This financial barrier limits access to cutting-edge neurodiagnostic and therapeutic technologies, particularly for organizations with constrained budgets or in developing regions.

• Increased Privacy Concerns

The use of neurophotonics technologies for brain imaging and manipulation raises ethical questions regarding the collection, storage, and sharing of sensitive neuroimaging data. Patients and research participants may have concerns about the potential misuse or unauthorized access to their neural information, leading to hesitancy in participating in neurophotonics studies or undergoing neuroimaging procedures. Regulatory frameworks for protecting patient privacy and ensuring data security are essential but can also add complexity and compliance burdens for neuroph otonics developers and healthcare providers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Neurophotonics Market Scope

The market is segmented on the basis of type, application, and end-use. The growth amongst these segments will help your meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Type

• Microscopy
• Spectroscopy
• Multimodal

Application

• Research
• Diagnostics
• Therapeutics

End-Use

• Hospitals
• Clinics
• Others

Neurophotonics Market Regional Analysis/Insights

The market is analyzed, and market size insights and trends are provided by country, type, application and end-use as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.   

North America dominates the market due to substantial healthcare expenditures and improved healthcare outcomes, particularly in the U.S. This dominance is driven by significant investments in medical research and advanced healthcare technologies, which enhance diagnostic and therapeutic capabilities. Additionally, a strong focus on innovation and the presence of leading healthcare institutions contribute to the region's prominent position in the market.

Asia-Pacific is expected to experience significant growth in the market, primarily due to substantial investments in research and development. This region's robust scientific community, combined with increasing government funding and collaboration between academic institutions and industry, drives advancements in neurophotonics technology. Additionally, the growing prevalence of neurological disorders and the rising demand for innovative diagnostic and therapeutic solutions further boost market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Neurophotonics Market Analysis

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 글로벌 요양원 및 장기 요양 시설 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

•  히타치 주식회사(일본)
•  Artinis Medical Systems(네덜란드)
•  케언 리서치(영국)
•  Femtonics Ltd(헝가리)
•  Carl Zeiss AG(독일)
•  fNIR 디바이스 LLC(미국)
•  HemoPhotonics(스페인)
•  호리바 주식회사(일본)
•  Leica Microsystems(독일)
•  인텔리전트 이미징 이노베이션(미국)

SKU-61765